2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association - Wikidata - awgldk - TriplyDB

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

http://www.wikidata.org/entity/Q29614695

about

Efficacy and safety of ablation for patients with non-paroxysmal atrial fibrillation Exercise-based cardiac rehabilitation for adults with atrial fibrillation Factor Xa Inhibitors: A Step Forward in the Treatment of Atrial Fibrillation?Anticoagulation in atrial fibrillation: NOAC's the word Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study How and When to Screen for Atrial Fibrillation after Stroke: Insights from Insertable Cardiac Monitoring Devices How we treat bleeding associated with direct oral anticoagulants Atrial fibrillation and silent stroke: links, risks, and challenges Edoxaban in venous thromboembolism and stroke prevention: an appraisal Shensongyangxin Capsules for Paroxysmal Atrial Fibrillation: A Systematic Review of Randomized Clinical Trials Emerging Tools for Stroke Prevention in Atrial Fibrillation Almanac 2015: atrial fibrillation research in Heart How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis Oral direct thrombin inhibition: a double-edged sword?Accuracy of methods for detecting an irregular pulse and suspected atrial fibrillation: A systematic review and meta-analysis Atrial fibrillation in heart failure: what should we do?Practical and clinical considerations in assessing patients with atrial fibrillation for switching to non-vitamin K antagonist oral anticoagulants in primary care Direct Oral Anticoagulants for the Prevention of Stroke in Patients with Nonvalvular Atrial Fibrillation: Understanding Differences and Similarities Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?Atrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment options Antithrombotic management of atrial fibrillation in the elderly Clinical use of rivaroxaban: pharmacokinetic and pharmacodynamic rationale for dosing regimens in different indications Stroke prevention in older adults with atrial fibrillation The role of dronedarone in the treatment of atrial fibrillation/flutter in the aftermath of PALLAS Catheter ablation versus rate control for atrial fibrillation: what have we learnt from the ARC-HF trial?Predicting adverse drug reactions in older adults; a systematic review of the risk prediction models Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon Contraception and cardiovascular disease Calcium dysregulation in atrial fibrillation: the role of CaMKII An evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillation --LAA Occluder View for post-implantation Evaluation (LOVE)--standardized imaging proposal evaluating implanted left atrial appendage occlusion devices by cardiac computed tomography.Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Atrial fibrillation: inflammation in disguise?Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed Non-vitamin-K oral anticoagulants and laboratory testing: now and in the future : Views from a workshop at the European Medicines Agency (EMA)Ablation of Atrial Fibrillation in Combination with Left Atrial Appendage Occlusion in A Single Procedure. Rationale and Technique Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology.Minimizing bleeding risk in patients receiving direct oral anticoagulants for stroke prevention

P2860

Q24186195-93508F9E-67B3-40AB-82F2-CC1980DFCF54 Q24195079-43275057-FACC-40DF-9072-D4B260613775 Q24199050-E81E0AA1-EC34-445F-97A1-360F5D45A779 Q24618605-9FBE8178-41E9-447E-AB30-9697DF9DF0B8 Q24658646-28B456C0-DBC1-4554-8AE2-1F363C9A2433 Q26747267-4A086812-1DC8-43F8-902A-BE091AD7CDA6 Q26748343-482C3F78-8F40-4828-BD66-6C8CF0A8BC54 Q26750435-832871D7-CDDA-475E-B76E-3FB4E943A8D0 Q26751263-9443A9F2-B304-4904-A895-C3A150A9D988 Q26753062-8C273238-BC1B-40B8-8D42-B4C36B28DC06 Q26765023-C369005A-DE75-4BCD-8E38-44F3B0A4CFAF Q26770598-049493D6-9CF0-4892-B4B2-170C7EE88A7F Q26776413-33DAB2FD-1D0C-445C-9897-D21DAD2CD539 Q26777365-67C40F4E-8CF2-422D-83F9-06DFBB08E1A2 Q26780154-A3D68892-FAAD-4210-96D5-E3E502264410 Q26783524-ABBF67C5-D08A-4A90-8A78-1928F0BB4CC0 Q26784426-5A94F911-C81E-4695-89E2-307E765BF6FF Q26785480-60CCF3A2-C469-4BC6-9FDD-02F3477501C4 Q26787046-D1444181-ED8C-40CE-B971-503CF9036585 Q26799394-4376D2EA-0E27-4249-8317-EB5D40B1A773 Q26799571-1D9A6019-5764-46F4-ACE6-5C38FA9B2501 Q26827113-3B5288F9-673E-481C-BCCE-1076ADAAD5BB Q26828817-463393BB-9B86-4460-BD20-1C80F857F4EB Q26830227-7820C41F-203F-4571-915C-13060161F9BA Q26853369-1D66B6C2-A2A9-46B9-A239-BDDF5D4B7F03 Q27002352-6A7FAD20-3B78-40B3-B39E-1B9512D43325 Q27006081-CDD8DDD0-733B-48C1-AED8-2287C0CFBDA3 Q27006860-BEEE2FD0-66CF-486D-BD28-04B9EB882AE3 Q27026895-FE9EC278-30C4-4FB4-B514-9075C43F7676 Q27027326-52524A9F-1219-4A50-8029-E571AB7B97BC Q27027953-82515987-7957-42BF-984C-6A45DC70AF48 Q27312052-0CC95534-1E49-43EE-999F-909BF3BC1B47 Q27337981-AD0840F7-8C33-4236-8DA5-979DD6BAA234 Q27341873-6FB5866D-6041-4A25-9591-863B97A4E8A1 Q27693290-C42A304C-75D8-45CC-9A5B-FE1D90A9715F Q28067358-2D84A5DC-07E6-4D2B-919F-29245B9EE629 Q28067412-5DB860C0-89D1-49EC-A16F-B2121D27F5BE Q28068321-78A69C64-4215-4F2C-8CFE-5EC61696FCD9 Q28069234-5CF9B62F-E46B-4AF1-82F9-869AA94FFE16 Q28069809-B8290C71-9DF9-4BF7-85C3-40BF2F3EF3F3

P2860

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

http://www.wikidata.org/entity/Q29614695

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

2012 focused update of the ESC ...... opean Heart Rhythm Association

@ast

2012 focused update of the ESC ...... opean Heart Rhythm Association

@en

type

label

2012 focused update of the ESC ...... opean Heart Rhythm Association

@ast

2012 focused update of the ESC ...... opean Heart Rhythm Association

@en

prefLabel

2012 focused update of the ESC ...... opean Heart Rhythm Association

@ast

2012 focused update of the ESC ...... opean Heart Rhythm Association

@en

P1433

Q29614695-210E8109-7038-4D39-ABDF-962A2695CBD0

P1476

Q29614695-E17E7174-E0FF-4194-8F74-E7B870EC6B23

P2093

Q29614695-00ACE64E-C625-4D3F-B598-48577FC7BF6E

Q29614695-1023A60F-869D-44D8-8F56-10E3B0939374

Q29614695-110FC3A3-87E4-4043-837F-E4919773EA5A

Q29614695-1303E88A-C119-419A-A513-4E9B45BFF161

Q29614695-357EB627-5DAC-4EE1-9CD6-64EFE7A69CAF

Q29614695-7EFFEDAC-17D0-4D10-9F8E-436FF09570B0

Q29614695-80AC55EE-B9DE-4305-A958-85BFC8E0C21D

Q29614695-9E58381E-BC59-4DD2-AAB0-8B9D4C6D3053

P304

Q29614695-183FDB5C-0531-4012-9311-ECC18A2EE416

P31

Q29614695-1A522E6D-1258-4BD4-ACC5-510012C3C626

P3181

Q29614695-D3DF3172-D280-4055-9945-2FF24687790B

P356

Q29614695-FF57574C-B231-47DE-BDC5-69878BADDD67

P407

Q29614695-5B92B446-98C4-4597-A485-1242FD7C2B4E

P433

Q29614695-F3F01FD6-01AA-4A5E-AF22-B2A188F77E79

P478

Q29614695-ADBED095-5F9B-49D8-BC4A-5682FDEC2632

P577

Q29614695-3FA2BAA4-E79D-407A-9394-B4FD5F76DD36

P5875

Q29614695-43135A5C-32DC-4668-9753-B82A1E1DA304

P698

Q29614695-2F2E80E7-C212-4A06-91E0-EC288AA9891E

P921

Q29614695-48023CDF-5D37-4474-B027-0223BA79DBE6

P3181

P356

P1433

European Heart Journal

P1476

2012 focused update of the ESC ...... opean Heart Rhythm Association

@en

P2093

Atar D

http://www.w3.org/2001/XMLSchema#string

Camm AJ

http://www.w3.org/2001/XMLSchema#string

De Caterina R

http://www.w3.org/2001/XMLSchema#string

Hindricks G

http://www.w3.org/2001/XMLSchema#string

Hohnloser SH

http://www.w3.org/2001/XMLSchema#string

Kirchhof P

http://www.w3.org/2001/XMLSchema#string

Lip GY

http://www.w3.org/2001/XMLSchema#string

Savelieva I

http://www.w3.org/2001/XMLSchema#string

P304

2719-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

743250

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/EURHEARTJ/EHS253

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230741365

http://www.w3.org/2001/XMLSchema#string

P698

22922413

http://www.w3.org/2001/XMLSchema#string

P921

atrial fibrillation